AI 检索
AI 阅读
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Safety and efficacy of standard of care (SOC) teclistamab (TEC) in patients with relapsed/refractory multiple myeloma (RRMM), a single center experience

Ariel Grajales-Cruz,Sushmita Khadka,Brandon Blue,Doris Hansen,Omar Castaneda Puglianini,Ciara Freeman,Gabriel De Avila,Leonel Ochoa-Bayona,Hien Liu,Taiga Nishihori,Frederick Locke,Ken Shain,Rachid Baz,Melissa Alsina

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2023）

引用 0|浏览9
暂无评分
关键词
refractory multiple myeloma,teclistamab,teclistamab,rrmm
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要